BioStock: Regulatory focus for Neola Medical

Lund-based Neola Medical can look back on an eventful period when reporting the third quarter of 2022. Positive study results and a successful capital raise provide a stable foundation for the future, where the focus will be on the regulatory work ahead of the market launch. BioStock contacted Neola Medical’s CEO Hanna Sjöström to find out more about her view of the third quarter and what she sees ahead of her for 2023.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/11/regulatory-focus-for-neola-medical/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se